WO2001067106A8 - Identification of g protein-coupled receptor ligands and modulators - Google Patents

Identification of g protein-coupled receptor ligands and modulators

Info

Publication number
WO2001067106A8
WO2001067106A8 PCT/US2001/007304 US0107304W WO0167106A8 WO 2001067106 A8 WO2001067106 A8 WO 2001067106A8 US 0107304 W US0107304 W US 0107304W WO 0167106 A8 WO0167106 A8 WO 0167106A8
Authority
WO
WIPO (PCT)
Prior art keywords
protein
modulators
identification
mutants
coupled receptor
Prior art date
Application number
PCT/US2001/007304
Other languages
French (fr)
Other versions
WO2001067106A3 (en
WO2001067106A2 (en
Inventor
Gabriel Berstein
Original Assignee
Millennium Pharm Inc
Gabriel Berstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc, Gabriel Berstein filed Critical Millennium Pharm Inc
Priority to AU2001249107A priority Critical patent/AU2001249107A1/en
Publication of WO2001067106A2 publication Critical patent/WO2001067106A2/en
Publication of WO2001067106A8 publication Critical patent/WO2001067106A8/en
Publication of WO2001067106A3 publication Critical patent/WO2001067106A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention features methods of assaying for ligands and/or modulators of G protein-coupled receptors, for example, orphan G protein-coupled receptors. The methods of the invention feature constitutively active arrestin mutants, in particular, phosphorylation independent mutants. Also described are specific phosphorylation independent arrestin mutants and methods of making such mutants.
PCT/US2001/007304 2000-03-03 2001-03-05 Identification of g protein-coupled receptor ligands and modulators WO2001067106A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001249107A AU2001249107A1 (en) 2000-03-03 2001-03-05 Methods of assaying for g protein-coupled receptor ligands and modulators

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18670600P 2000-03-03 2000-03-03
US60/186,706 2000-03-03

Publications (3)

Publication Number Publication Date
WO2001067106A2 WO2001067106A2 (en) 2001-09-13
WO2001067106A8 true WO2001067106A8 (en) 2002-02-14
WO2001067106A3 WO2001067106A3 (en) 2002-04-11

Family

ID=22685983

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/007304 WO2001067106A2 (en) 2000-03-03 2001-03-05 Identification of g protein-coupled receptor ligands and modulators

Country Status (2)

Country Link
AU (1) AU2001249107A1 (en)
WO (1) WO2001067106A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046763A1 (en) * 2000-12-04 2002-06-13 Novo Nordisk A/S Method of identifying compounds capable of acting as agonists or antagonists of g-protein coupled receptors
AU2002358469A1 (en) * 2001-12-21 2003-07-15 7Tm Pharma A/S Modified receptors for the discovery of therapeutic ligands
AU2003300424A1 (en) * 2002-10-11 2004-05-04 7Tm Pharma A/S Method for enhancing and prolonging the bioluminescence resonance energy transfer (bret) signal in a bret assay and a substrate solution for use in a bret assay
JP2007504482A (en) * 2003-01-17 2007-03-01 アクララ バイオサイエンシーズ, インコーポレイテッド Deorphanization of receptors using a tagged molecule library
US20060246507A1 (en) * 2003-01-22 2006-11-02 7Tm Pharma A/S Beta-arrestin based screening assays
FR2934684B1 (en) 2008-07-31 2012-11-16 Cis Bio Int METHOD OF DETECTING INTERNALIZATION OF MEMBRANE PROTEINS.

Also Published As

Publication number Publication date
AU2001249107A1 (en) 2001-09-17
WO2001067106A3 (en) 2002-04-11
WO2001067106A2 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
WO1999061471A3 (en) Human transmembrane proteins
WO2001098351A3 (en) G-protein coupled receptors
CA2305810A1 (en) Methods of assaying receptor activity and constructs useful in such methods
WO2000000610A3 (en) Human signal peptide-containing proteins
AU5579099A (en) Electrochemical affinity assay
WO2000015793A3 (en) Human gpcr proteins
WO2001057085A3 (en) G-protein coupled receptors
WO2001087937A3 (en) G-protein coupled receptors
WO2001098323A8 (en) G-protein coupled receptors
WO2001067106A3 (en) Identification of g protein-coupled receptor ligands and modulators
WO2001051638A3 (en) Drug metabolizing enzymes
WO2001090334A3 (en) Drug metabolizing enzymes
WO2002004612A3 (en) Drug metabolizing enzymes
WO2000028032A3 (en) Human cell surface receptor proteins
AU2002210982A1 (en) Method of screening antiplatelet
WO2000055332A3 (en) Human regulators of intracellular phosphorylation
WO2001072836A3 (en) G-protein coupled receptors
WO2002034783A3 (en) Transmembrane proteins
WO2002026825A3 (en) G-protein coupled receptors
WO2001027146A3 (en) Chemokine receptor
WO2000065054A3 (en) Human membrane-associated proteins
WO2001066742A3 (en) G-protein coupled receptors
WO2001059127A3 (en) Drug metabolizing enzymes
WO2001079468A3 (en) Drug metabolizing enzymes
WO2002012467A3 (en) Drug metabolizing enzymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 37/2001 UNDER (81) ADD "US"

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP